Biotech · Private company · New York, NY, US

Ubiquitx, Inc.

Track this companyFree. Adds Ubiquitx, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Chimeric Ligands for Induced Proximity (CLIP) platform for targeted proteome editing to treat severe alcoholic hepatitisFiscal year 2025 · $391.5KNIH RePORTER 1R43AA032456-01 · fetched Nov 12, 2026
Chimeric Ligands for Induced Proximity (CLIP) platform for targeted proteome editing and upregulation of antigen presentationFiscal year 2024 · $299.9KNIH RePORTER 1R41AI186686-01 · fetched Nov 12, 2026
Computational design and evaluation of peptide-guided protein degradersFiscal year 2024 · $306.9KNIH RePORTER 1R41GM153081-01 · fetched Nov 12, 2026
Computational design and evaluation of peptide-guided protein degradersFiscal year 2024 · $6.5KNIH RePORTER 3R41GM153081-01S1 · fetched Nov 12, 2026